About the TAVR Procedure
Open-heart surgery has traditionally been the most common treatment of severe aortic stenosis. High risk patients at North Shore-LIJ now have access to a newer and less invasive procedure known as transcatheter aortic valve replacement (TAVR).
Similar to a technique used to implant cardiac stents into clogged arteries, the TAVR procedure involves a physician guiding a catheter to the heart with an artificial valve attached. Using transesophageal echo and fluoroscopic imaging, the valve is checked for proper placement. The valve expands and is anchored inside the aorta and blood flow is restored.
Who is TAVR for?
Because of this new, less-invasive treatment option, high risk patients with severe aortic stenosis are now candidates for valve replacement.
Patients with severe aortic stenosis are generally older with multiple medical conditions. This can put them at very high risk if traditional surgical procedures are performed. Previously these patients had little or no treatment options.
Traditional cardiac surgery involves an incision along the sternum (sternotomy) to access the heart. The TAVR procedure replaces a diseased aortic heart valve percutaneously – meaning through the skin – without a stermotomy and without surgical removal of the diseased valve.
The procedure has shown to significantly improve survival and quality of life when compared to medical therapies.
Bringing the Best Technology to Our Patients
North Shore-LIJ is a leader in the treatment of aortic valve disease, offering patients advanced aortic valve procedures that are not available everywhere. Currently, North Shore-LIJ offers patients two options for transcatheter aortic valve replacement and the selection depends on the needs of the patient.
In 2011, LIJ Medical Center
was the first facility in Queens and Long Island to implant the FDA approved Sapien Transcathether Aortic Valve, manufactured by Edwards Lifesciences. This FDA approved device is now also available at North Shore University Hospital, Southside Hospital and Lenox Hill Hospital.
Medtronic CoreValve US Pivotal Trial
– North Shore University Hospital and Lenox Hill Hospital are among 40 hospitals in the nation selected in 2010 to participate in this trial that evaluates the investigational aortic valve replacement procedure. Participants in trial benefit from four different valve sizes and three entry sites based on the anatomy and size of the patient’s arteries.
to find out more about the Edwards valve and the Medtronic clinical trial.
A True, Patient-Centered “Heart Team”
Both of the transcatheter valve replacement procedures involve a highly specialized team to ensure optimal patient care. Our “TAVR Coordinators” act as single points of contact for patients and families. They facilitate tests and treatments and answer any questions that may arise along the way.
There is very close collaboration between the patient and family, the Coordinator, and the cardiovascular specialists, including:
- Cardiac Surgeons
- Interventional Cardiologists
- Vascular Surgeons
- Cardiac Anesthesiologists
- Cardiac Imaging and Radiologists
A Cutting Edge Facility, Designed for TAVR
North Shore-LIJ has built several hybrid operating rooms for these procedures that combine the imaging capabilities of a traditional cardiac catheterization laboratory with the functionality of a cardiac operating room. This allows interventional cardiologists and surgeons to collaborate on the most complex cardiac cases and exemplifies North Shore-LIJ’s commitment to the latest advances in cardiac care.
Back to Top